Today the FDA issued a draft guidance that shines a spotlight on the importance of assessing food allergens that are not one of the nine major food allergens (milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, sesame and soybeans). “The nine major food allergens don’t currently represent all foods nationwide that people are allergic to or that cause food hypersensitivities,” said CFSAN Director Susan Mayne, Ph.D., in an agency release. “This draft guidance is part of the FDA’s efforts to evaluate emerging evidence about other non-listed food allergens that can cause serious reactions in a consistent and transparent manner, which can inform potential future actions to better help protect the health of consumers.”
The draft, “Evaluating the Public Health Importance of Food Allergens Other Than the Major Food Allergens Listed in the Federal Food, Drug, and Cosmetic Act”, targets immunoglobulin E antibody (IgE)-mediated food allergies, which can cause severe and life-threatening reactions such as anaphylaxis. The document reviews the evidence that establishes a food as a cause of IgE-mediated food allergy and scientific factors, such as prevalence, severity and allergenic potency, that the FDA would consider in evaluations. It also reviews the agency’s recommendations for identifying and evidence to determine the public health importance of a non-listed food allergen.
Comments on the draft guidance can be submitted by August 17, 2022.